(Q40983022)

25 September 2017

Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

9 April 2023

3

Rosenberg SA

1 reference

25 September 2017

Krikorian JG

1

1 reference

25 September 2017

Burke JS

2

1 reference

25 September 2017

Kaplan HS

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1979

1 reference

full work available at URL

25 September 2017

http://www.nejm.org/doi/pdf/10.1056/NEJM197903013000902

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

The New England Journal of Medicine

9 April 2023

published in

1 reference

25 September 2017

300

1 reference

25 September 2017

452-458

1 reference

25 September 2017

9

1 reference

Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases

25 September 2017

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Journal of the National Cancer Institute

9 April 2023

3

38

741

Berg

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Second malignancies complicating Hodgkin's disease in remission

9 April 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Multiple primary cancer risk after therapy for Hodgkin's disease

9 April 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Risk of new cancers in patients with Hodgkin's disease

9 April 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

9 April 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Hematologic neoplasia in patients treated for Hodgkin's disease

9 April 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

9 April 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas

9 April 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

9 April 2023

Composite lymphoma

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Conversion of Hodgkin’s Disease to Lymphoblastic Lymphosarcoma

9 April 2023

15

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Immunopathology of follicular lymphomas. A model of B-lymphocyte homing

9 April 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

National Cancer Institute Monograph

9 April 2023

20

36

363

Kaplan

1973

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report

9 April 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Combined modality therapy of Hodgkin's disease.A report on the stanford trials

9 April 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

9 April 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Nonparametric Estimation from Incomplete Observations

9 April 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Cancer chemotherapy reports

9 April 2023

27

6

375

Coltman

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

9 April 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Immunologic characterization of human malignant lymphomas

9 April 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature

9 April 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

The simultaneous presentation of Hodgkin's disease of myeloma

9 April 2023

31

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Simultaneous occurrence of myeloma and Hodgkin's disease

9 April 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Letter: Second malignancies in treated Hodgkin's patients and splenectomy

9 April 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers

9 April 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis

9 April 2023

36

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor

9 April 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome

9 April 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM197903013000902

9 April 2023

Identifiers

1 reference

25 September 2017

1 reference